2023-507527-28-00招募中2 期
Assessing the Safety, Immune Response, and Early Efficacy of a Candida Vaccine in Women with Recurrent Vulvovaginal Candidiasis: A Randomized Controlled Study
适应症
试验速览
- 阶段
- 2 期
- 状态
- 招募中
- 入组人数
- 251
- 试验地点
- 8
研究概览
简要总结
暂无简介。
入排标准
- 年龄范围
- 18 years 至 64 years（18-64 Years）
- 性别
- Female
- 接受健康志愿者
- 是
入选标准
- 未提供
排除标准
- 未提供
研究者
Cristina Alaimo
Scientific
LimmaTech Biologics AG
研究点 (8)
Loading locations...
相似试验
招募中
1 期
Phase I study to evaluate safety and immunogenicity of V-212 in healthy adult volunteers.2024-516008-41-00Virometix AG60
招募中
1 期
A study to assess the safety and immunogenicity of a therapeutic hepatitis B virus vaccine, in healthy adults (RUBY).Hepatitis B2025-521169-28-00AstriVax16
暂停
3 期
A study to compare efficacy, safety, and immune response of GME751 and EU-authorized Keytruda in adult participants with untreated metastatic lung cancer2023-506882-70-00H e x a l AG89
招募中
1 期
An early Phase 1b Study to assess how safe and effective is the treatment with drugs, called Mosunetuzumab or Glofitamab in Combination with drugs called, CC-220 and CC-99282 in Patients with B-Cell Non-Hodgkin Lymphoma.2023-505185-28-00F. Hoffmann-La Roche AG52
招募中
2 期
Preliminary study: Safety and Immunological Response following COVID-19 Vaccination in COVID-19 survivorsCOVID-19 survivorsCOVID-19 VaccinationTCTR20210720005Faculty of Medicine Siriraj Hospital180